P719: RANDOMIZED PHASE 1-2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS

• Guillermo Garcia-Manero,
• Kimo Bachishvili,
• Elizabeth A. Griffiths,
• Amer M. Zeidan,
• Elie Traer,
• Lalit Saini,
• Harshad Amin,
• Sanjay Mohan,
• Michael Lübbert,
• Lori Maness-Harris,
• James M Foran,
• Dominik Selleslag,
• Blanca Xicoy Cirici,
• Daniel Aaron Pollyea,
• David Sallman,
• Aref Al-Kali,
• Jesus Berdeja,
• Haifa Kathrin Al-Ali,
• Nancy Y Zhu,
• Patricia Font Lopez,
• Guillermo Sanz Santillana,
• Valeria Santini,
• Habte A. Yimer,
• Larry D Cripe,
• Victor Priego,
• Olatoyosi Odenike,
• Bert Heyrman,
• David Valcarcel,
• Pankit Vachhani,
• Yuri Sano,
• Beloo Mirakhur,
• Aram Oganesian,
• Harold Keer,
• Abdulraheem Yacoub

Affiliations

Guillermo Garcia-Manero

1 The University of Texas MD Anderson Cancer Center, Houston, United States

Kimo Bachishvili

2 University of Alabama at Birmingham O’Neal Comprehensive Cancer Center, Birmingham, United States

Elizabeth A. Griffiths

3 Roswell Park Comprehensive Cancer Center, New York, United States

Amer M. Zeidan

4 Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, United States

Elie Traer

5 Oregon Health and Science University, Portland, United States

Lalit Saini

6 London Health Sciences Centre, London, Ontario, Canada

Harshad Amin

7 Boca Raton Cancer Research, Plantation, United States

Sanjay Mohan

8 Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, United States

Michael Lübbert

9 Faculty of Medicine and Medical Center - University of Freiburg, Frieburg, Germany

Lori Maness-Harris

10 University of Nebraska Medical Center, Omaha, United States

James M Foran

11 Mayo Clinic, Jacksonville, United States

Dominik Selleslag

12 AZ Sint Jan, Dept of Hematology, Bruges, Belgium

Blanca Xicoy Cirici

13 Institut Català d’Oncologia Badalona Hospital Universitari Germans Trias i Pujol, Badalona, Spain

Daniel Aaron Pollyea

14 University of Colorado School of Medicine, Division of Hematology, Aurora, United States

David Sallman

15 Moffitt Cancer Center, Tampa, United States

Aref Al-Kali

16 Mayo Clinic, Rochester, Rochester, United States

Jesus Berdeja

17 Sarah Cannon Research Institute, Nashville, United States

Haifa Kathrin Al-Ali

18 Universitätsklinikum Halle, Germany

Nancy Y Zhu

19 University of Alberta Hospital - Hematology Research, Edmonton, Alberta, Canada

Patricia Font Lopez

20 Hospital General Universitario Gregorio Maranon, Madrid, Spain

Guillermo Sanz Santillana

21 Hospital Universitario y Politécnico La Fe, Valencia, Spain

Valeria Santini

22 MDS Unit, Hematology, AOUC, University of Florence, Florence, Italy

Habte A. Yimer

23 Texas Oncology - Tyler (USO), Tyler, United States

Larry D Cripe

24 Indiana University Health, Indianapolis, United States

Victor Priego

25 Regional Cancer Care, Bethesda, United States

Olatoyosi Odenike

26 University of Chicago, Chicago, United States

Bert Heyrman

27 Zna Middelheim, Antwerp, Belgium

David Valcarcel

28 Hospital Universitario Vall d Hebron, Barcelona, Spain

Pankit Vachhani

2 University of Alabama at Birmingham O’Neal Comprehensive Cancer Center, Birmingham, United States

Yuri Sano

29 Astex Pharmaceuticals, Inc.

Beloo Mirakhur

29 Astex Pharmaceuticals, Inc.

Aram Oganesian

29 Astex Pharmaceuticals, Inc.

Harold Keer

29 Astex Pharmaceuticals, Inc.

Abdulraheem Yacoub

30 The University of Kansas Cancer Center, Westwood, United States